Guidance Document  
 
A guidance document issued by the Ministry for Primary Industries  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Equids  
LIVEQUID.GEN  
      
 Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  1 of 21 
 
 
 Title 
Guidance Document : Equids . 
About this document  
This guidance document contains information about acceptable ways of ensuring compliance with the 
requirements in t he Import Health Standard ( IHS): Equids . 
Any guidance on how to comply with the applicable requirements may not be the only way to achieve 
compliance. Stakeholders are encouraged to discuss  departures from the approaches outlined in this 
guidance document with the Ministry for Primary Industries (MPI) to avoid expending resources on the 
development of alternative approaches which may later be considered unsuitable.  
The term “must” is not typ ically used in guidance. In this particular document if the term “must” is used, it is 
used in the context of quoting or paraphrasing the requirements set out in the related IHS: Equids . 
Related Requirements  
Import Health Standard: Equids  
Document  history  
Refer to Appendix 1.  
Contact Details  
For further information and questions about this guidance document, please contact:  
 
Ministry for Primary Industries  
Regulation & Assurance  
Animal Imports  
PO Box 2526  
Wellington 6140  
Email: animal.imports@mpi.govt.nz  
Disclaimer  
This guidance does not constitute, and should not be regarded as, legal advice . While every effort has been 
made to ensure the information in this guidance is accurate, the Ministry for Primary Industries does not accept 
any responsibility or liability whatsoever for any error of fact, omission, interpretation or opinion that may be 
present, however it may have occurred.  
Copyright  
Crown copyright ©. This copyright work is licensed under the Creative Commons Attribution 3.0 New Zealand 
licence. In essence, you are free to copy, distribute and adapt the work, as long as you attribu te the work to the Ministry for Primary 
Industries and abide by the other licence terms. To view a copy of this licence, visit http://creativecommons.org/licenses/by/3.0/nz/ . 
Please note that n o governmental emblem, logo or Coat of Arms may be used in any way which infringes any provision of the Flags, 
Emblems, and Names Protection Act 1981 or would infringe such provision if the relevant use occurred within New Zealand. 
Attribution to the Minis try for Primary Industries should be in written form and not by reproduction of any such emblem, logo or Coat of 
Arms.  
Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  2 of 21 
 
 
 Contents  Page 
1 Purpose  3 
2 Background  3 
3 Definitions  3 
4 Importer Responsibilities  3 
5 Guidance  3 
5.1 Equivalence  3 
5.2 Harmonised system (HS) codes  4 
5.3 Exporting country systems and certification  4 
5.4 Animal identification  5 
5.5 Diagnostic tests, vaccines and treatment  5 
5.6 Timing   6 
5.7 Transport  6 
5.8 Residency in more than one country  6 
5.9 Equine disease free zones  7 
5.10  Contingency planning  7 
5.11  Transitional facilities for equids  8 
5.12  Summary information on approved countries  8 
5.13  The documentation that must accompany goods  8 
5.14  Tick examination  8 
5.15  Vector protection and vec tor-proof  8 
5.16  Animal welfare  8 
6 Specified Requirements for Identified Risk Organisms  10 
6.1 Model veterinary certificate  10 
Appendix 1 – Sample identification silhouette  20 
Appendix 2 – Document History  21 
 
  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  3 of 21 
 
 
 1 Purpose  
(1) This guidance document has been issued to accompany the IHS: Equids . This guidance document 
should be read in conjunction with that IHS.  
(2) This document includes:  
a) Countries with MPI -approved exporting systems to import  equids  into New Zealand.  
b) A model v eterinary certificate.  
c) Links to n egotiated country specific veterinary certificates.  
2 Background  
(1) The IHS: Equids , which this guidance document accompanies, contains generic import requirements. 
These are the rules to manage the biosecurity risk of importi ng equids  from all countries that can meet 
the requirements of the IHS and in doing so meet New Zealand’s appropriate level of protection. The 
generic IHS serves as the basis for country -to-country (bilateral) negotiations. This guidance document 
contain s a model veterinary certificate and the bilaterally -agreed veterinary certification for trade in  
equids . This country -specific veterinary certificate represents what will be certified prior to exporting 
consignments of  equids  from the country specified.  
(2) General information about importing animal products can be found here:  
http://www.mpi.govt.nz/importing/food/   
3 Definitions  
(1) Refer to Schedule 2 of the IHS: Equids . 
4 Import er Responsibilities  
(1) The costs to MPI in performing functions relating to the importation of  equids  will be recovered in 
accordance with the Biosecurity Act 1993 (the Act) and any regulations made under that Act. All costs 
involved with documentation, tra nsport, storage and obtaining a biosecurity clearance must be covered 
by the importer or agent.  
5 Guidance  
5.1 Equivalence  
(1) MPI may accept an alternative method, system or process that can be shown to achieve the 
biosecurity requirements of the IHS (i.e. equivalence).  
(2) MPI’s preference is that the exporting country’s Competent Authority makes equivalence requests. 
Equivalence requests can be lodged with animal.imports@mpi.govt.nz . 
(3) An import permit is not req uired to import  equids  into New Zealand from Australia if the requirements of 
the IHS are met.  
(4) An import  permit may be required where specific equivalence measures are approved by MPI. A n 
import permit serves as evidence of equivalence decisions and will be written as specific notes in the 
special conditions section of the permit.  
(5) Import permit application f orms can be found on the MPI website at : Forms and templates  
(6) Completed applications are lodged with animal.imports@mpi.govt.nz . Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  4 of 21 
 
 
 5.2 Harmonised system (HS) codes  
(1) The Harmonised System is an international product numbering classification developed by the World 
Customs Organization (WCO). The New Zealand Harmonised System is found here: 
https://www.mbie.govt.nz/business -and-employment/business/trade -and-tariffs/tariffs -in-new-zealand/  
(2) Animals  imported using the IHS will be under one of the following HS Codes:  
 
HS Code  Commodity Description  
0101  Horses, asses, mules and hinnies; live  
5.3 Exporting country systems and certification  
5.3.1 Approval for exporting systems  
(1) MPI recommends Competent Authorities that request the approval of their exporting systems refer to 
Section 3 of the Code  titled Quality of Veterinary Services  and the MPI document Recognition of 
Expor t Controls and Certification Systems for Animals and Animal Products , to prepare evidence for 
MPI regarding capabilities and preferences of the exporting country’s Competent Authority.  
(2) The table below lists those exporting countries that meet the requireme nts set out in the IHS: Equids . 
 
Countries with approved 
exporting systems  Biosecurity Plan Name  Date agreed  
Australia  N/A Trade ongoing  
Canada  N/A Trade ongoing  
European Union  N/A Trade ongoing  
Hong Kong  N/A Trade ongoing  
Japan  N/A Trade ongoing  
Macau  N/A 23 August 2016  
Singapore  N/A 18 January 2014  
United States of America  N/A Trade ongoing  
5.3.2 Agreed country specific veterinary certificates  
(1) Requests from exporting countries to negotiate veterinary certification for the import of  equids  into New 
Zealand will be prioritised according to MPI resources available at the time of application.  
(2) A model veterinary certificate is provided in this guidance document and can be used by the 
Competent Authority as a reference for country -specif ic veterinary certificate negotiation.  
(3) All country -specific veterinary certificates agreed between an exporting country’s Competent Authority 
and MPI are included in the table below:  
 
Country  Link to certificate  S27 CTO direction 
#  Date agreed  Date applic able 
for use  
     
(4) Country -specific veterinary certificates with equivalent measures will be recorded with a number 
relevant to a Chief Technical Officer (CTO) direction under section 27(1)d(iii) of the Act, to enable 
border staff to clear the goods and record the number in the MPI database.  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  5 of 21 
 
 
 (5) When a newly negotiated country -specific veterinary certificate replaces one which is currently in use, 
the application of new import conditions will apply according to the dates listed in the table. At that time 
previous veterinary cert ificates for that country can no longer be used.  
(6) When a country -specific veterinary certificate is agreed, there will be a four -month transition period to 
allow animals  to be prepared in accordance with the new conditions. During transition, both the old  and 
the new import conditions are acceptable. After transition, the previous veterinary certificate for that 
country can no longer be used.  
5.4 Animal identification  
(1) Each equid must be implanted with a microchip for identification. International Standards Org anisation 
(ISO) Standard microchips meeting specifications 11784 or Annex A of ISO Standard 11785 should be 
used.  
(2) If the microchip does not meet these ISO Standards, it is the importer’s responsibility to ensure that the 
microchip can be read upon entry to  New Zealand. This may mean that the importer will need to 
provide a microchip reader (at the importer’s expense) to enable the chip to be read. Some ports of 
entry may have microchip readers capable of reading other types of microchip and this should be 
checked with the port before travel.  
(3) An identification silhouette can also be used in addition to providing microchip information. This 
ensures equids can still be identified if any issues with reading the microchip on arrival occur. An 
example silhouette has been provided in Appendix 1.  
5.5 Diagnostic tests , vaccines and treatment  
(1) MPI lists all approved diagnostic tests and vaccines in the MPI document: Approved Diagnostic Tests, 
Vaccines, Treatments a nd Post -Arrival Testing Laboratories for Animal Import Health Standards, 
MPI-STD-TVTL. . 
(2) Where OIE recommended diagnostic tests and vaccines are listed, details can be found in the OIE 
Manual of Diagnostic Tests and Vaccines  found on the OIE website: Terrestrial Manual Online Access 
- OIE - World Organisation for Animal Health  
(3) The OIE Terrestrial Animal Health Code  chapter listing the prescribed and alternative diagnostic tests 
for OIE listed diseases is found on the OIE website: Terrestrial Code Online Access - OIE - World 
Organisation for Animal Health  
5.5.1 Equine influenza (EI) vaccines  
(1) Equids with a long history of vaccination against EI are likely to have been given a vaccine which does 
not comply with the requirement for the vaccine to include both clade  1 and clade 2 of the Florida sub -
lineage (FC1 and FC2, respectively).  
(2) For equids receiving a primary series to meet the EI requirements for import, the vaccine must meet 
the IHS requirements.  
(3) For equids who have previously completed a primary series and a re receiving a booster to meet the EI 
requirements for import, only the most recent booster needs to comply with the IHS requirements. 
These equids are not required to start a new primary series with a compliant vaccine.  
5.5.2 Negative, stable or declining EVA t itres  
(1) Equine viral arteritis (EVA) titre tests should be performed at the same laboratory, preferably on the 
same day, (to minimise laboratory variation).  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  6 of 21 
 
 
 (2) One doubling of titre (i.e. 1:8 first sample and 1:16 second sample) between the first sample and th e 
final pre -export isolation sample will be acceptable as normal laboratory variation. This doubling would 
be regarded as “stable”.  
(3) Two doublings in titre (i.e. 1:8 first sample and 1:32 second sample, which is the same as a fourfold 
increase) may require  further testing at MPI’s discretion.  
(4) If the first sample result  was 1:4 and the second sample result  was 1:64 (four doublings) then  that 
demonstrates active infection and antibody titres are still being stimulated to counter the infection.  In 
this case t he animal could not  travel.  
5.6 Timing  
(1) To calculate the timeframes for testing, treatments, vaccinations, and examinations specified in the 
IHS, count the day of sampling for testing, application of treatment or vaccine, or day of examination, 
as Day 0.  
(2) For post-arrival quarantine (PAQ), the PAQ perio d (Day 0) will commence on the day the aircraft lands 
in New Zealand (irrespective of the time of day). If equids arrive on a different aircraft/ship and are 
arriving into the transitional facility (TF) at differ ent times, the PAQ period  (Day 0) will commence on 
the day the last horse in the intake enters the TF.  
5.7 Transport  
(1) Approved places of first arrival (POFAs) may be an airport or seaport. Only certain POFAs are 
approved to accept equids.  
(2) A list of approved air ports and their approved types of cargo can be found here: 
http://www.mpi.govt.nz/news -and-resources/resources/registers -and-lists/pla ces-of-first-arrival -
airports/ . 
(3) A list of approved seaports and their approved types of cargo can be found here: 
http://www.mpi.govt.n z/news -and-resources/resources/registers -and-lists/places -of-first-arrival -
seaports/ .  
(4) Combined shipping of e quids from multiple locations are considered to be a single consignment, thus 
the pre -export isolation (PEI) period starts when the last horse of t he entire consignment (no matter the 
location) enters PEI. The minimum period of PEI will be the same for all equids in the consignment. In 
some cases a portion of the consignment of equids may experience a lon ger PEI period due to 
logistics.  
5.8 Residency in more than one country  
(1) Where the specified requirements for risk organisms in Part 2  of the IHS requires a minimum residency 
period in the exporting country immediately prior to export to New Zealand, equids may reside in more 
than one country of export pro vided the countries are approved and of at least equal health status.  
(2) Equivalent residency must be approved by MPI prior to import and will be recorded on the import 
permit.  When requesting equivalent residency, copies of the export certificates, or a lett er from the 
Competent Authority from the country or countries of residence should be provided at the time of 
import permit application.  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  7 of 21 
 
 
 5.9 Equine disease free zones  
(1) An Equine Disease Free Zone (EDFZ) is the establishment of a zone free from specified diseases. The 
concept of an EDFZ is an extension of the concepts of zoning and compartmentalisation already 
defined and described in the OIE Code.  Countries may consider establishing an EDFZ where it is not 
possible to control and eradicate all equine diseases in other parts of the country.  Equids within the 
EDFZ are protected from the specified diseases by the application of sound biosecurity management, 
appropriate monitoring and surveillance, certification standards and procedures, contingency planning, 
identification and traceability.  
(2) Where the specified requirements for risk organisms in Part 2  of the IHS requires a minimum residency 
period in the exporting country immediately prior to export to New Zealand, equids may use their 
residency period in an MPI -approved EDFZ to meet specified residency requirements (depending on 
what diseases the EDFZ  is free from).  
(3) The table below lists MPI-approved  EDFZs . 
 
EDFZ  Locations  Date agreed  Time period  
Conghua EDFZ  Conghua, Guangzhou, People’s 
Republic of China  6 June 2019  Permanent  
5.10 Contingency planning  
(1) In the case of a delay in unloading from the aircraft or ship at a POFA, plans should include, but is not 
limited to, provision of extra feed/water, veterinary care, and handling of deceased animals in the case 
of death or euthanasia.  
(2) Equids that do not typically require post -arrival quarantine will require a  pre-approved  contingency plan 
in the event that the equids need to be held due to a non -compliance related to biosecurity risk 
organisms.  
(3) In the event where equids cannot be cleared at the border due to a biosecurity non -compliance, equids 
may need to be transported t o and held at a transitional facility approved under the TF standard 
Transitional Facility Stand ard for Equids , MPI-STD-EQUIDS  or an approved holding place under the 
TF standard for Transitional Facilities for General Uncleared Risk Goods , TFGEN  until the non-
compliance is resolved.  
(4) The TF standard TFGEN and its associated guidance document can be found here: 
http://mpi.govt.nz/importing/borde r-clearance/transitional -and-containment -facilities/requirements/ .  
(5) Holding places may be stables or farms that can meet the requirements and be approved under 
section 4.5 of TFGEN. Prior to the importation of equids, the facility and operational procedure s in the 
form of a TF manual should be verified and be deemed appropriate for the isolation of non -compliant 
equids.  
(6) In the event that a holding place is required, other animals located there may be removed and the 
holding place can then be temporarily app roved for the time period needed for resolving the non -
compliance.  
(7) The table below lists holding facilities with pre -approved TF manuals that may be approved as an 
additional holding place in th e event of a non -compliance . 
 
Name of facility  Location  
  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  8 of 21 
 
 
 5.11 Transitional facilities for equids  
(1) IRT New Zealand  
126 Muir Road , Papakura , Auckland, New Zealand  
Tel: +64 9 2 97 2022 | Fax: +64 9 298 6066  
www.irt.com  
5.12 Summary information on approved countries  
(1) The following countries are approved by MPI to export equids to New Zealand:  
a) Australia:  
i) Permit to import only required if requesting an equivalence.  
ii) Pre-export isolation not required, except in areas/zones infected with cattle ticks (minimum 
3 days).  
iii) Post-arrival quarantine not required if import requirements are met.  
b) Canada , European Union  member states, Hong Kong , Japan , Macau, Singapore and USA: 
i) Permit to import required.  
ii) Pre-export isolation required (minimum 21 days).  
iii) Post-arrival quarantine required (minimum 14 days).  
5.13 The documentation that must accompany goods  
(1) Documentation accompanying the consignment that is sent to t he MPI Veterinarian should include 
information on previous illnesses and/or treatments of equids being released from pre -export isolation.  
5.14 Tick examination  
(1) Visual tick examinations are performed at the border by the MPI Veterinarian for equids imported fro m 
Australia. All other countries will have tick inspections performed at an approved transitional facility, 
within 24 hours of arrival into New Zealand.  
(2) Examination before export must involve a systematic approach and the inspection should be done by 
the registered attending veterinarian under supervision of the Official Veterinarian. The inspection 
should include close examination of the ears, false nostrils, under -body areas (axilla, inguinal region 
and under the jawbone), perineum, mane and tail.  
5.15 Vector  protection and vector -proof  
(1) The MPI expectations of vector protection against Culicoides  midges can be modelled off the OIE 
Code  recommendations found in the African Horse Sickness Chapter Article 12.1.10. Protecting 
animals from Culicoides attacks.   
Guid ance on how to meet the MPI definition for vector -proof can be found in the following DEFRA 
article : African Horse Sickness: Maximising Equine Housing Vector Protection . 
5.16 Animal welfare  
(1) Owners and people in charge of animals in New Zealand must comply with the Animal Welfare Act 
1999.  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  9 of 21 
 
 
 (2) Compliance with the minimum standards contained in the codes of welf are can be used as evidence of 
compliance with the Animal Welfare Act.  
(3) The Code of Welfare: Horses and Donkeys provide s information to the owners and persons in charge 
of horses and donkeys about the standards they must achieve in order to meet the obligat ions under 
the Animal Welfare Act. (http://www.mpi.govt.nz/protection -and-response/animal -welfare/codes -of-
welfare/ ).  
(4) The Code of Welfare: Transport within New Zealand provide s information to the owners and persons in 
charge of the transport of animals about the standards they must achieve in order to meet their 
obligations under the Animal Welfare Act (https://www.mpi.govt.nz/dmsdocument/1407 -transport -
within -new-zealand -animal -welfare -code -of-welfare -2016 ).  
(5) During post arrival quarantine, if an equid is experiencing pain or distress that is severe and/or 
untreatable, humane euthanasia should be carried out according to Minimum Standard 15 of the Code 
of Welfare: Horses and Donkeys.  
(6) Equids under 4 months of ag e should be transported with their dam.  
(7) Pregnant mares must not be more than 300 days gestation at the scheduled time of arrival.  
5.16.1  Welfare for transport by sea  
(1) Equids that are transported by sea should meet the requirements in the MPI Standard for the Export of 
Horses from New Zealand  by sea.  
5.16.2  Welfare for transport by air  
(1) International Air Transport Associati on (IATA) Live Animal Regulations  are the minimum acceptable 
standard for all carriers. As these regulations are continually being updated, it is important to ensure 
that the current edition of the regulations is used.  
(2) Equids cannot be less than 4 weeks of  age if traveling by air.  
 
  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  10 of 21 
 
 
 6 Specified Requirements for Identified Risk Organisms  
6.1 Model veterinary certificate  
(1) Below is a model veterinary certificate for trade in  equids . This model meets the requirements of the 
IHS.  
 
Part 1: Details of dispatched cons ignment  1.1.  Consignor (Exporter):  
Name:  
Address:  
 1.2.  Certificate reference number:  
 
1.3.  Competent Authority:  
 
1.4.  Consignee (Importer):  
Name:  
Address:  
 
 
1.5.  Country of origin:  
ISO Code*  1.6.  Zone or compartment of origin:**  
 
1.7.  Country of destination :  
ISO Code*  1.8.  Zone o r compartment of destination:**  
1.9.  Place of origin:  
Name:  
Address:  
1.10.  Place of export : 1.11.  Date of departure:  
1.12.  Means of transport:  
 
    Aeroplane           Ship  
 
Identification:  
 1.13.  Expected border post:  
1.14.  Description of commodity:  
 1.15.  Commodity Code (ISO Code*):  
1.16.  Total number of  animals : 
1.17.  Treatment of vehicle used to transport horse(s) to port of departure (e.g. residual insecticide – date of treatment, 
chemical(s) used, and the active ingredient(s):  
 
1.18.   Treatment of container(s) (e.g. residual insecticide – date of treatment, chemical(s) used, and the active 
ingredient(s):  
1.19.  Identification of container/serial number:  
1.20.  Identification of commodity:  
Species (Scientific Name)  ID Number/Details  Breed/Category  Age Quantity  ID System  
      
      
      
      
 
*Optional  
**If referenced in Part II  
 Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  11 of 21 
 
 
 
Part 2:  Veterinary Information  Country:  Certificate reference number:  
I, the undersigned Official Veterinarian, certify  that in relation to  the equids  described above , the following requirements  
have been met : 
Disease freedom and residency  
(1) The equids were free from all quarantine restrictions prior to export to New Zealand.  
(2) The equids resided in an MPI -approved EDFZ during the 180 days prior to export  
(a) <Name of EDFZ> is free from the following diseases:  
Pre-export isolation (PEI)  
(3) All pre -export isolation requirements according to Part 3 – Pre-Export Isolation of the IHS: Equi ds were met.  
(4) Pre-export isolation period: from _______________ to ________________  
(5) The microchip identification of each equid was verified at the start of PEI.  
(6) During pre -export isolation, the equids:  
(a) Were not naturally mated or artificially inseminated, o ther than required for certification; and  
(b) Remained free from evidence of infectious or contagious disease and had no contact with animals except 
those that meet all requirements for import into New Zealand; and  
(c) Were protected from insect vectors  
Inspection  
(7) The equids were thoroughly examined for ectoparasites and seeds within 24 hours of export by an Official 
Veterinarian. A thorough and systematic approach was used and included a close visual and tactile examination 
of the ears, false nostrils, under -body areas (axilla, inguinal region, and under the jawbone), perineum, mane and 
tail. 
(8) The equids were inspected by an Official Veterinarian within 24 hours of export and were found to be free of 
clinical signs of infectious or contagious disease of biosecurity concern to New Zealand and were fit to travel.  
Testing, vaccines, and treatments  
(9) The microchip identification of each equid was verified at each test, vaccine, and/or treatment.  
(10) Diagnostic testing was conducted at a laboratory approved by the Competent  Authority to conduct the required 
export testing.  
(11) Laboratory samples were collected, processed, and stored as recommended in the OIE  Terrestrial Animal Health  
Code  and/or Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, or as described in MPI-STD-TVTL  
(12)  Diagnostic test(s) and vaccines were those that have been approved by MPI and documented in MPI-STD-TVTL  
(13) Any products  and vaccine s administered to satisfy import requirements were administered according to the 
recommendations of the manufacturer  unless otherwise approved by MPI . 
(14) Any vaccine(s) administered to satisfy import requirements was/were either the final dose of a primary vaccination 
course or the recommended booster to complement the primary course.  
(15) Product names, manufacturers, active ingredients (where applicable), dos e and dates of treatment are recorded 
on this veterinary certificate.  
(16) Vaccine names,  the virus types and strains included in the vaccine (where applicable), and date of vaccination  
are recorded on this veterinary certificate.  
Transport  
(17) No animals other th an those that meet the import requirements for entry into New Zealand have been transported 
with the equids to the port of departure or on the aircraft or ship.  
(18) No equid in the consignment is less than:  
(a)  4 weeks of age if travelling by air; or  
(b) 7 months of age if traveling by sea.  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  12 of 21 
 
 
 (19) No equid in the consignment will be more than 300 days pregnant at the scheduled time of import.  
(20) The vehicle in which the equids was/were transported to the port of departure was cleaned, disinfected and 
treated with an effective r esidual insecticide prior to loading the equid(s). The date of treatment, the chemical(s) 
used, and the active ingredient(s) are recorded on this veterinary certificate or separate MPI -approved attestation.  
(21) The cargo space of the aircraft transporting the  equids has been disinfected and treated with an effective residual 
insecticide prior to loading the equid(s). A treatment certificate will accompany the equids to be available for 
inspection at the port of arrival.  
(22) The equids  were  loaded into containers t hat are  (delete as applicable) : 
(a) New and treated with an effective residual insecticide prior to loading the equids. The date of treatment, 
the chemical(s) used, and the active ingredient(s) are recorded on the veterinary certificate  or a separate 
MPI-appro ved attestation;  or  
(b) Cleaned and disinfected with an effective virucidal disinfectant, and treated with an effective residual 
insecticide prior to loading the equids. The date of treatment, the chemical(s) used, and the active 
ingredient(s) are recorded on  the veterinary certificate  or a separate MPI -approved attestation.  
(23) Only sterile peat, soft board, treated wood shavings, s hredded paper, or other inert products were loaded for use 
as bedding during transportation . All feed and bedding is free from seeds.  
African horse sickness virus (AHS)  
(24) The equids were kept in an AHS free country or zone  as defined in the OIE Terrestrial Animal Health  Code  since 
birth or for at least 40 days prior to export; and 
(a) Were not vaccinated against AHS within the 40 days  prior to export ; and  
(i) Did not transit through an infected zone during transportation to the place of export ; or 
(ii) Were protected from Culicoides  attacks at all times when transiting through an infected zone ; or 
(25) The equids were kept in an AHS infected or at-risk country or zone as defined in the OIE Terrestrial Animal Health 
Code ; and  
(a) Were not vaccinated against AHS within the 40 days prior to expo rt; and  
(b) Were held in PEI on  a vector -protected  premises : 
(i) For a period of at least 28 days and a serological test  to detect antibodies against the AHSV 
group, was carried out with a negative result on a blood sample collected at least 28 days after 
introd uction into vector -protected PEI; or  
(ii) For a period of at least 40 days and serological tests to detect antibodies against AHSV were 
carried out with no significant increase in antibody titre on blood samples collected on two 
occasions, with an interval of n ot less than 21 days, the first sample being collected at least 7 days 
after introduction into vector -protected PEI; or  
(iii) For a period of at least 14 days and an agent identification test was carried out with a negative 
result on a blood sample collected no t less than 14 days after introduction into vector -protected 
PEI; or  
(iv) For a period of at least 40 days and were vaccinated in accordance with the recommendations of 
the manufacturer, at least 40 days prior to export , against all serotypes whose presence in the 
source population has been demonstrated through a surveillance programme in accordance with 
the OIE Code  chapter for Infection with African horse sickness virus , and were identified in the 
accompanying certification as having been vaccinated; and  
(c) Were protected from Culicoides  attacks at all times  during transportation (including transportation to and at 
the place of export ). 
Bacillus anthracis (anthrax)  
(26) The equids were kept for the 20 days prior to export on premises where no case of anthrax was offici ally declared 
during that period; or  
(27) The equids were vaccinated in accordance with the recommendations of the manufacturer not less than 20 days 
and not mo re than 1 year prior to export.  
 Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  13 of 21 
 
 
 Borna disease virus  
(28) The equids were  kept since birth or for at least the 90 days prior to export  in a country recognised  by MPI to be 
free from Borna disease ; or  
(29) The equids were  kept since birth or for at least the 90 days prior to export on premises in which no case of Borna 
disease was r eported in the 1 year prior to export .   
Burkholderia mallei  (glanders)  
(30) The equids were  kept since birth or for at least the 180 days  prior to  export in a country  or zone  free of glanders 
as de fined  in the OIE Terrestrial Animal Health Code  ; or 
(31) The equids were  kept since birth or for at least the 180 days  prior to  export on premises where no case of 
glanders was reported during the 1 year prior to export, and w ere isolated for at least 30 days prior to export, and 
during that time were subjected to a test for glanders  with negative results, carried out on two samples taken 21 to 
30 days apart . 
Cochliomyia hominivorax and Chrysomya bezziana (New World and Old World screwworm):  
(32) The equids were  kept since birth or for at least the 21 days prior to export in a country recognised by MPI as free 
from New World and Old World screwworm fly and where no case of screwworm fly myasis was reported in the 1 
year prior to export; or  
(33) Immediately prior to entering PEI, and again  at the end of PEI, the equids  
(a) Were thoroughly examined for infested wounds, under the direct supervision of an official veterinarian, and 
no infestation was found in any animal; and  
(b) Any wounds were prophylactically treated with an oily larvicide that is a pproved by the Veterinary Authority 
for the prevention of screwworm fly, and applied in accordance with the recommendations of the 
manufacturer; and  
(c) Were dipped, sprayed, or otherwise treated, immediately after inspection, with a product that is approved 
by the Veterinary Authority for the control of New World or Old World screwworm, under the supervision of 
an official veterinarian and in accordance with the recommendations of the manufacturer; and  
Name of product(s): ________________________________________________________________  
Active ingredients: _________________________________________________________________  
Dose rate: _____________________________________________________________________ ___ 
Date of treatments: _________________________________________________________________  
(d) Immediately prior to loading, the equids  to be exported were inspected, on the premises of origin, by an 
official veterinarian. After inspection for wounds with egg masses or larvae of New World or Old World 
screwworm, any infested anim al has been rejected for export.  
Eastern and  Western equine encephalomyelitis viruses (EEE/WEE)  
(34) The equids were  kept since birth or for at least the 90 days prior to export in a country recognised by MPI as free 
from EEE and WEE; or  
(35) The equids were  from an EEE/WEE infected country and showed no clinical sign of equ ine encephalomyelitis 
during the 90 days prior to export ; and  
(a) Were kept f or the 90 days prior to export o n premises where no case of equine encephalomyelitis was 
officially reported during that period; or  
(b) Were kept in PEI for the 21 days prior to export an d were protected from insect vectors at all times during 
PEI and transportation to the place of export ; or 
(c) Were vaccinated in accordance with the recommendations of the manufacturer not less than 15 days and 
not more than one year prior to export.  
Ectopara sites  
(36) The equids did not require any PEI; and  
(a) Were treated within 24 -48 hours prior to travel with a broad -spectrum ectoparasiticide effective against 
ticks and applied in accordance with the recommendations of the manu facturer ; and Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  14 of 21 
 
 
 (b) At the final inspection prior to export:  
(i) There was no evidence of ectoparasite infection; or  
(ii) Ectoparasites were found and the equids in the consignment were re -treated, and then re -
inspected no less than 48 hours after treatment, until no ectoparasites we re found. (If the exporting 
country is not free of piroplasmosis, this clause does not apply and equids must be free from 
ectoparasite infection at the inspection in the 24 hours prior to scheduled export ); or 
(37) The equids were exported from a cattle tick -infested area and did not require PEI for any other identified risk 
organisms and were:  
(a) Thoroughly examined for ticks within prior to entry into PEI under the supervision of the Official 
Veterinarian. A thorough and systematic approach was used and included a close visual and tactile 
examination of the ears, false nostrils, under -body areas (axilla, inguinal region, and under the jawbone), 
perineum, mane and tail; and  
(b) Kept in PEI for the 3 days prior to export and be fully stabled at all times; and  
(c) Maintained  tick free for the entire duration of PEI; and  
(d) Treated twice with a broad -spectrum ectoparasiticide effective against ticks applied in accordance with the 
recommendations of the manufacturer, the first treatment prior to entry into PEI and the second treat ment 
within 48 hours prior to export;  and 
(e) At the final inspection prior to export:  
(i) There was no evidence of ectoparasite infection; or  
(ii) Ectoparasites were found and the equids in the consignment were re -treated, and then re -
inspected no less than 48 hours after treatment, until no ectoparasites were found. (If the exporting 
country is not free of piroplasmosis, this clause does not apply and equids must be free from 
ectoparasite infection at the inspection in the 24 hours prior to scheduled export ); or 
(38) The equids required PEI for identified risk organisms other than ectoparasites and were:  
(a) Thoroughly examined for ectoparasites within 24 hours after entry into PEI under the supervision of the 
Official Veterinarian. A thorough and systematic approach was used  and included a close visual and tactile 
examination of the ears, false nostrils, under -body areas (axilla, inguinal region, and under the jawbone), 
perineum, mane and tail; and  
(b) Treated twice for ectoparasites:  
(i) The first treatment was given within 24 hour s after entry into PEI after ectoparasite examination; 
and  
(ii) The second treatment was given within 24 -48 hours prior to export; and  
(c) The product(s) used is a broad -spectrum ectoparasiticide effective against ticks and was applied in 
accordance with the reco mmendations of the manufacturer; and  
(d) At the final inspection prior to export:  
(i) There was no evidence of ectoparasite infection; or  
(ii) Ectoparasites were found and the equids in the consignment were re -treated, and then re -
inspected no less than 48 hours after treatment, until no ectoparasites were found. (If the exporting 
country is not free of piroplasmosis, this clause does not apply a nd equids must be free from 
ectoparasite infection at the inspection in the 24 hours prior to scheduled export ); or 
Name of product(s): ________________________________________________________________  
Active ingredients: ___________________________________ ______________________________  
Dose rate: ________________________________________________________________________  
Date of treatments: _________________________________________________________________  
Endoparasites  
(39) The equids did not require any PEI and we re treated within 24 -48 hours prior to travel with a broad spectrum 
anthelmintic applied in accordance with the recommendations of the manufacturer; or  
(40) The equids required PEI and were treated within 24 hours after entry into PEI with a broad spectrum anth elmintic 
applied in accordance with the recommendations of the manufacturer  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  15 of 21 
 
 
 Name of product(s): ________________________________________________________________  
Active ingredients: _________________________________________________________________  
Dose rate: ________________________________________________________________________  
Date of treatments: _________________________________________________________________  
Equine arteritis virus (EVA) (excluding un -weaned foals under 180 days of age accompanied by their dam)  
(41) For uncastrated male equids , the equids showed no clinical signs of EVA during the 28 days prior to export; and 
(a) Were isolated for the 28 days prior to expor t and was/were subjected to a test for EVA carried out on a 
single blood sample collected during the 21 days prior to export with a negative result; or  
(b) Were subjected between six and nine months of age to a test for EVA : 
(i) With a negative result and was/ were immediately vaccinated against EVA and regularly 
revaccinated in accordance with the recommendations of the manufacture r; or 
(ii) With a positive result, followed at least 14 days later by a second test showing a stable or 
decreasing titre and were immediately vaccinated a gainst EVA and regularly revaccinated in 
accordance with the  recommendations of the  manufacturer; and  
(iii) Vaccinations for export were administered not less than 28 days prior to export; or  
(c) Were iso lated and not earlier than 7  days of commencing isolation were  subjected to a test for EVA  on a 
blood sample with a negative result; and 
(i) Were then immediately vaccinated in accordance with the recommendations of the manufacturer; 
and 
(ii) Were kept separated from other equids for 21 days following vaccination; and  
(iii) Were re gularly revaccinated in accordance with the  recommendations of the  manufacturer; and  
(iv) Vaccinations for export were administered not less than 28 days prior to export; or  
(d) Were  subjected to a test for EVA carried out on a blood sample with a positive result ; and 
(i) Were subsequently test mated to two mares within 180 days prior to export. The mares were 
subjected to two tests for EVA with negative results on blood samples collected at the time of test 
mating and again 28 days after the mating; or  
(ii) Were subjected to a test for EVA with a negative result, carried out on semen collected during the 
180 days prior to export; or  
(iii) Were subjected to a test for EVA with a negative result, carried out on semen collected within 180 
days  after the blood sample was te sted, then immediately vaccinated and regularly revaccinated in 
accordance with the recommendations of the manufacturer . Vaccinations for export were 
administered not less than 28 days prior to export.  
(42) For equids  other than uncastrated males , the equids sh owed no clinical signs of EVA during the 28 days prior 
to export; and 
(a) Were kept o n premises where no animals have shown any signs of EVA in the 28 days prior to export; and  
(i) Were subjected to a test for EVA carried out on blood samples collected either once  within the 21 
days prior to export with a negative result, or on two occasions at least 14 days apart within the 28 
days prior to export, which demonstrated stable or declining antibody titres; or  
(ii) Were regularly vaccinated in accordance with the recommendations of the manufacturer. 
Vaccinations for export were administered not less than 21 days prior to export; or  
(b) Were isolated for the 28  days prior to export and during this period showed no sign of EVA.  
Equine herpesvirus -1 (EHV -1) 
(43) The equids wer e kept for at least the 21 days prior to  expor t on premises where no case of EHV-1 infection was 
reported during that period.  
 Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  16 of 21 
 
 
 Equine infectious anaemia virus  (EIA)  
(44) The equids were  showing  no clinical signs of EIA in the 48 hours prior to export; and 
(a) Were kept since birth or for at least the 90 days prior to  export on premises where no official case of EIA 
was reported during that period ; and  
(b) Were subjected to a diagnostic test for EIA with negative results, on samples collected in the 21 days prior 
to export.  
Equine influenza virus (EI) 
(45) The equids were from an EI free country, zone or compartment as defined in the OIE Terrestrial Animal Health 
Code  , since birth or for at least the 21 days prior to export and in the case of a vaccinated domestic equid, 
information on its vaccination status is include d in the veterinary certificate. EI vaccines contained equivalent 
strains of EI virus as recommended by the OIE Expert Surveillance Panel on Equine Influenza Vaccine 
Composition; or  
(46) The equids were  from a co untry, zone or compartment not known to be free from EI as defined in the OIE 
Terrestrial Animal Health Code  and were subjected to PEI for the 21 days prior to export and showed no clinical 
sign of EI during isolation nor on the day of export;  and 
(a) Were vac cinated in accordance with the recommendations of the manufacturer between 21 and 90 days 
prior to export either with a primary course or a booster  (excluding un -weaned foals less than 180 days of 
age accompanied by their dam). EI vaccines contained equiva lent strains of EI virus as recommended by 
the OIE Expert Surveillance Panel on Equine  Influenza Vaccine Composition;  or 
(b) Were subjected to an agent identification test with negative results, on samples collected on two 
occasions; in the 5 -7 days after entry into PEI, and the second in the 4 days prior to export.  
Hendra virus  
(47) The equids were  kept since birth or for at least the 90 days prior to export in a country recognised by MPI as free 
from Hendra; or  
(48) The equids were  kept since birth or for at least the 90 days prior to export on premises where no case of infection 
in animals or humans has been reported during that period, and Hendra is notifiable in the country of export; or  
(49) The equids were  vaccinated against Hendra virus in accordance with the recom mendations of the manufacturer, 
not less than 14 days and not more than 1 year prior to export.  
Hypoderma bovis and Hypoderma lineatum  (warble fly myiasis)  
(50) The equids were  kept since birth or for at least the 90 days prior to export in a country or zone re cognised by MPI 
as free from warble fly, and where no case of warble fly has been reported during the 1 year prior to export; or   
(51) The equids were  treated with an ectoparasiticide approved by the Veterinary Authority as capable of killing warble 
fly larvae,  applied in accordance with the recommendations of the manufacturer in the 48 hours prior to export 
and were showing no clinical signs of warble fly disease at the final inspection prior to export.  
Name of product(s): ________________________________________________________________  
Active ingredients: _________________________________________________________________  
Dose rate: ________________________________________________________________________  
Date of treatment: __ _______________________________________________________________ _ 
Japanese encephalitis virus (JE) 
(52) The equids were  kept since birth or for at least the 21 days  prior to export  in a country recognised  by MPI as free 
from JE ; or 
(53) The equids were kept for the 2 1 days prior to export in PEI, protected from vectors at all times during PEI and 
transportation to the place of export; or  
(54) The equids were  vaccinated in accordance with the recommendations of the manufacturer not less than 7 days 
and no more than 1 year p rior to export.  
Nipah virus  
(55) The equids were  kept since birth or for at least the 90 days prior to export in a country approved by MPI as free 
from Nipah; or  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  17 of 21 
 
 
 (56) The equids were  kept since birth or for at least the 90 days prior to export on premises where no c ase of infection 
in animals or humans has been reported during that period, and Nipah is notifiable in the country of export.  
Rabies virus  
(57) The equids were  kept since birth or for at least the 180 days  prior to  export in a rabies free country  as defined in 
the OIE Terrestrial Animal Health  Code  ; or 
(58) The equids were  permanently identified with a microchip and the microchip nu mber stated in the certificate; and  
(a) Were kept for the 6 months prior to export on premises where there has been no case of  rabies for at least 
12 months prior to export; or  
(b) Were vaccinated or revaccinated in accordance with the recommendations of the manufacturer.  
Salmonella abortus equi (equine salmonellosis)  
(59) The equids were  kept since birth or for at least the 90 days prior to export on premises where no case of equine 
salmonellosis ( S. abortus equi ) has been reported during that period . 
Taylorella equigenitalis (contagious equine metritis [CEM])  
(60) The equids were  kept, since birth or for at least the 60 days prior to exp ort, in a country recognised by MPI as free 
from contagious equine metritis (CEM), and where no case of CEM has been reported in the 2 years prior to 
export; or  
(61) The equid is a gelding or a foal  less than 180 days of age accompanied by their dam; or  
(62) The eq uids:  
(a) Were  kept, since birth or for at least 60 days prior to export on premises where no case of CEM has been 
reported during that period; and  
(b) Have had no contact with CEM directly, through breeding (naturally or via artificial insemination) with an 
infected equid, or indirectly by passing through an infected premises, during the 60 days prior to export; 
and 
(c) Were subjected to a test for CEM in the 30 days prior to export, with negative results;  
(i) Stallions and colts were sampl ed two times at intervals of 4 -14 days. Sampling sites are the 
urethra, urethral fossa and its sinus, and the penile sheath;  
(ii) Mares and  fillies must be sampled two times at intervals of 4 -14 days. Sampling sites are the 
clitoral fossa and sinuses; and  
(d) Did not receive antibiotics within 7  days (systemic treatment) or 21 days (local treatment) before the first 
sample collection or during the CEM sampling period; and  
(e) Have not been naturally mated or inseminated with semen from a CEM -untested stallion since the date of 
first sampling for CEM . 
Theileria equi  and Babesia caballi  (equine piroplasmosis)  
(63) The equids were kept since birth or for at least the 30 days prior to export in a country recognised by MPI as free 
from equine piroplasmosis, that does not import seropositive equids (with the exception of horses temporarily 
imported for competition purposes), and where no case of equine piroplasmosis has been reported in the 2 years 
prior to export; or  
(64) The equids w ere subjected to IFAT and CFT serological diagnostic tests  and a PCR assay for eq uine 
piroplasmosis ( Theileria equi  and Babesia caballi ) with negative results , during the 30 days prior to export ; and 
(a) Were maintained free from ticks, by preventive treatment when necessary, during the 30 days prior to 
export; and  
(b) Have met the ectoparasit e requirements of this certificate.  
 
 
 Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  18 of 21 
 
 
 Trypanosoma equiperdum  (dourine)  
(65) The equids were kept since birth, or for the 180 days  prior to export , in a country which has been free from 
dourine for no t less than the 180 days prior to export; or  
(66) The equids were kept for the 180 days  prior to export o n premises where no case of dourine was officially 
reported during that period, and was/were subjected to a diagnostic test for dourine with negative results, during 
the 15 days prior to export.  
Trypanosoma evansi  (surra) 
(67) The equids were kept since birth or for at least the 60 days prior to export in a country recognised by MPI as free 
from surra, and where no case of surra has been reported in the 2 years prior to export; or  
(68) The equids were kept since birth or for at least the 60 days prior to export on premises where no case of surra 
has been reported during that period; and 
(a) Were kept for a minimum of 30 days prior to export in PEI and were protected from vectors at all times 
whilst in PEI and during transportation to the port of departure; and  
(b) Were subjected to diagnostic tests for surra with negative results, from samples collected in the 10 days 
after entry into PEI.  
Venezuelan equine encephalomyelitis virus (VEE)  
(69) The equids have not, during the past 180 days, been in any country in which VEE has occurred in the last two 
years and have not been vaccinated against VEE within the 60 days prior to export; or  
(70) The equids:  
(a)  Were vaccinated in accordance with the recommendations of the manufacturer agai nst VEE not less than 
60 days prior to export and were clearly identified with a permanent mark at the time of vaccination; and 
(b) Were kept in PEI for the 21 days prior to export and remained clinically healthy during that period; any 
animal which showed a r ise in temperature (taken daily) was subjected to a blood test for virus isolation, 
with negative results; and  
(c) Were protected from insect vectors during transportation to and from the PEI facility and during PEI; or  
(71) The equids have not been vaccinated agai nst VEE and 
(a) Were kept in PEI for the 21 days prior to export and remained clinically healthy during that period; any 
animal which showed a rise in temperature (taken daily) was subjected to a blood test for virus isolation, 
with negative results; and  
(b) Were subject ed to a diagnostic test for VEE , with negative results, conducted not less than 14 days after 
the commencement of PEI; and  
(c) Were protected from insect vectors during transportation to and from the PEI facility and during PEI.  
 
 Official Veterinarian  
Name:  
Address:  
Email:  
  
Signature:   
Date:  
 
 Official Veterinarian 
stamp  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  19 of 21 
 
 
 This table accompanies the veterinary certificate with reference number: ___________________________________________  
 Part 3 :  Details of animals  
 Horse Information  
Name  Identification  Breed  Age Name of owner  Address of owner  
      
Test information  
Animal identification  <Disease name>  <Disease name>  <Disease name>  <Disease name>  <Disease name>  <Disease name>  
 
Test 
sampling 
date 
Test type  
Result  
Test 
sampling 
date 
Test type  
Result  
Test 
sampling 
date 
Test type  
Result  
Test 
sampling 
date 
Test type  
Result  
Test 
sampling 
date 
Test type  
Result  
Test 
sampling 
date 
Test type  
Result  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vaccine information  
Animal identification  <Disease name>  <Disease name>  <Disease name>  <Disease name>  <Disease name>  
 
Name of vaccine  
  
Virus types and 
strains  
Date(s) of 
administration  
Name of vaccine  
Virus types and 
strains  
Date(s) of 
administration  
Name of vaccine  
Virus types and 
strains  
Date(s) of 
administration  
Name of vaccine  
Virus types and 
strains  
Date(s) of 
administration  
Name of vaccine  
Virus types and 
strains  
Date(s) of 
administration  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment information  
Animal identification  <Disease name>  <Disease name>  <Disease name>  <Disease name>  <Disease name>  
 
Name of product  
Active ingredients  
Dose rate  
Date(s) of 
administration  
Name of product  
Active ingredients  
Dose rate  
Date(s) of 
administration  
Name of product  
Active ingredients  
Dose rate  
Date(s) of 
administration  
Name of product  
Active ingredients  
Dose rate  
Date(s) of 
administration  
Name of product  
Active ingredients  
Dose rate  
Date(s) of 
administration  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (Note that this information is to be amended as appropriate to the exporting country)  
Official Veterinarian  
Name:   
Date:  
Signature:  Official Veterinarian 
stamp  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  20 of 21 
 
 
 
Appendix 1 – Sample identification silhouette  
This is only an example. Silhouettes from other sources are also acceptable.  
 
 
 
 
 
 
 
 
 
 
 
 
Description  
 
Head  
 
 
LF 
RF 
LH 
RH 
Body  
Microchip  Brand  Other  
 
 Official Veterinarian  
Name:   
Date:  
Signature:  Official Veterinarian 
stamp  Guidance Document : Equids  
 Draft for Consultation  [Document Date]  
Ministry for Primary Industrie s Page  21 of 21 
 
 
 Appendix 2  – Document History  
Date First Issued  Title Shortcode  
5 September 2019  Guidance Document:  Equids  LIVEQUID.GEN  
Date of Issued Amendments  Title Shortcode  
30 November 2021  
External Consultation  Guidance Document:  Equids  LIVEQUID.GEN